Lowe’s Sales Rose 8.3%. Margins Gave Back 80 Basis Points.

The headline change was the acceleration in revenue. Lowe’s reported Q2 FY2027 revenue of $25.96 billion, an increase of $2.00 billion, or 8.3%, from Q2 FY2026. This was also a step up from the $23.08 billion recorded in Q1 FY2027. Because no company guidance was supplied with the filing materials, the appropriate report-card comparison is the same quarter one year earlier rather than consensus estimates.

The earnings response was considerably less impressive. Diluted EPS was $4.27, exactly matching the prior-year quarter despite the higher revenue base. Gross margin contracted by 80 basis points to 33.0%, and operating margin also declined by 80 basis points to 13.7%, according to the Lowe’s Q2 FY2027 Form 10-Q. The quarter therefore produced more sales without an accompanying increase in per-share earnings.

Cash conversion weakened as well. Free cash flow was $3.12 billion, down $0.62 billion, or 16.6%, from $3.74 billion in Q2 FY2026. It remained substantial in absolute terms and followed $2.83 billion in Q1, but the year-over-year decline matters because it moved in the opposite direction from revenue. On a trailing basis, the supplied figures show $7.0 billion of free cash flow and a 6.4% free-cash-flow yield at the current share price.

The overall result is neutral rather than clearly positive or negative. Lowe’s demonstrated stronger demand in reported revenue, but the accompanying margin and cash-flow declines prevented that growth from improving the earnings profile. The quarter changes the composition of the result—more revenue, less profitability per dollar of sales—without materially changing the company’s near-term earning power.

The prior thesis required Lowe’s to stabilize after a multi-year revenue decline. Annual revenue fell from $97.06 billion in FY2023 to $86.38 billion in FY2024 and $83.67 billion in FY2025 before recovering 3.1% to $86.29 billion in FY2026. Q2 FY2027’s 8.3% increase is therefore evidence that the top-line contraction is no longer the only relevant trend. That is the strongest element of the quarter.

The problem is that revenue growth has not yet translated into operating leverage. Q2 operating margin of 13.7% remained healthy in isolation, but it was below 14.5% a year earlier. Gross margin followed the same pattern. With EPS flat at $4.27, shareholders received no year-over-year per-share earnings benefit from the additional $2.00 billion of quarterly revenue.

This result keeps the normalization thesis intact but incomplete. The bullish version of that thesis is not merely that sales recover; it is that recovered sales flow through a largely fixed operating structure and support higher earnings and cash generation. This quarter delivered the first condition but not the second. Until margins stabilize, it is too early to capitalize the improved sales trajectory at a materially higher valuation multiple.

Balance-sheet risk also remains relevant. The supplied FY2026 figures show $38.8 billion of net debt and negative equity of $7.44 billion. Lowe’s still produced meaningful free cash flow, and supplied FY2026 ROIC was 26.8%, but leverage and cyclicality reduce the margin for error if weaker profitability persists. The quarter neither resolves nor materially worsens that issue.

We retain fair value at $195 per share, approximately equal to the current price of $196.59. The stock trades at 16.6 times supplied trailing EPS of $11.83 and offers a 6.4% trailing free-cash-flow yield. Enterprise value to EBITDA was not disclosed in the supplied materials, so it is not used in the valuation.

Our scenario framework applies explicit earnings multiples to trailing EPS. The bear case uses 12.7 times $11.83 of EPS for a $150 value, reflecting persistent margin pressure and a cyclical slowdown. The base case uses 16.5 times trailing EPS for a rounded value of $195, assuming sales stabilize but margin recovery remains gradual. The bull case uses 20.3 times trailing EPS for $240, requiring durable growth and renewed operating leverage. With probabilities of 25%, 50% and 25%, respectively, the probability-weighted value is also $195.

The quarter does not justify changing those assumptions. Revenue was better, but EPS and free cash flow did not confirm a higher sustainable earnings base. Raising fair value solely because sales increased would ignore the simultaneous 80-basis-point declines in gross and operating margin. Conversely, cutting fair value would understate the significance of the revenue recovery and the continued generation of more than $3 billion of quarterly free cash flow.

At $196.59, fair value represents less than 1% downside. Under the stated verdict rule, the shares are Fairly Valued because the fair-value-to-price ratio is between 0.85 and 1.15. The market price already discounts a reasonable recovery without requiring the stronger assumptions embedded in the bull case.

The principal downside risk is that Q2’s revenue growth proves costly or temporary. If gross margin remains below the prior-year level and operating margin continues to contract, higher sales may not produce higher EPS. Another quarter combining strong revenue growth with flat or declining earnings would challenge the assumption that operating leverage eventually returns.

Free cash flow is the second test. Quarterly free cash flow fell 16.6% despite the revenue increase. One quarter is not enough to establish a structural deterioration, but continued divergence between sales and cash generation would weaken the 6.4% trailing free-cash-flow yield that supports the valuation. It would also make Lowe’s $38.8 billion of net debt more consequential.

The thesis could also prove too conservative. If revenue growth persists while gross and operating margins recover toward prior-year levels, EPS could move above the current trailing base and warrant a multiple closer to the bull case. That outcome requires evidence in reported profitability, not simply another quarter of higher sales.

The next quarterly filing should therefore be judged on three linked questions: whether revenue growth persists, whether gross and operating margins stabilize, and whether free cash flow resumes year-over-year growth. Q2 answered the first positively but left the other two unresolved. Until the financial statements show all three moving together, $195 remains the appropriate fair value.